MedPath

escitalopram

These highlights do not include all the information needed to use ESCITALOPRAM TABLETS safely and effectively. See full prescribing information for ESCITALOPRAM TABLETS. ESCITALOPRAM tablets, for oral use Initial U.S. Approval: 2002

Approved
Approval ID

d75e3b97-1ead-4e7b-9ae3-3626aede1efd

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Mar 3, 2025

Manufacturers
FDA

REMEDYREPACK INC.

DUNS: 829572556

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

escitalopram

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code70518-4300
Application NumberANDA078777
Product Classification
M
Marketing Category
C73584
G
Generic Name
escitalopram
Product Specifications
Route of AdministrationORAL
Effective DateMarch 3, 2025
FDA Product Classification

INGREDIENTS (10)

BUTYLATED HYDROXYANISOLEInactive
Code: REK4960K2U
Classification: IACT
CROSCARMELLOSE SODIUMInactive
Code: M28OL1HH48
Classification: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61U
Classification: IACT
HYDROXYPROPYL CELLULOSE (1600000 WAMW)Inactive
Code: RFW2ET671P
Classification: IACT
HYPROMELLOSESInactive
Code: 3NXW29V3WO
Classification: IACT
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
POLYETHYLENE GLYCOL, UNSPECIFIEDInactive
Code: 3WJQ0SDW1A
Classification: IACT
ESCITALOPRAM OXALATEActive
Quantity: 5 mg in 1 1
Code: 5U85DBW7LO
Classification: ACTIM
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JP
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

escitalopram - FDA Drug Approval Details